arrow
A

Alan V. Boddy

Univ South Australia
H指数:48
被引数:7,847

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Understanding Pharmacokinetic Variability of Pomalidomide: A Physiologically Based Pharmacokinetic Analysis of Disease-Related Physiology, Ethnicity, Hepatic Impairment, Food Effects, Drug Interactions, and Smoking

理解泊马利多米德的药代动力学变异性:基于生理学的药代动力学分析,探讨疾病相关生理、种族、肝功能损害、食物影响、药物相互作用和吸烟的影响

2026-09-300
OAAI
ALLG APML5: bioavailability and safety of oral arsenic trioxide assessed during consolidation therapy for APL

ALLG APML5:三氧化二砷口服生物利用度及安全性评估,评估时间在APL巩固治疗期间

2025-01-281
OA
Wnt receptor gene FZD1 was associated with schizophrenia in genome-wide SNP analysis of the Australian Schizophrenia Research Bank cohort

在澳大利亚精神分裂症研究银行队列的全基因组SNP分析中,Wnt受体基因FZD1与精神分裂症相关

2019-11-169
PREAI
A phase I pharmacokinetic and pharmacodynamic study of the oral mitogen-activated protein kinase kinase (MEK) inhibitor, WX-554, in patients with advanced solid tumours
2016-11-0113
OAAI